Solid operational aspects post-COVID, BMHS saw profit surge of nearly 200%
26 Aug 2024 11:08
As of June 2024, PT Bundamedik Tbk (BMHS) reported slight increase in revenue of 9% year-on-year (yoy) compared to H1 2021.
After suffering losses, Diagnos to acquire DNA data company Asa Ren
14 Mar 2024 14:02
PT Diagnos Laboratorium Utama Tbk (DGNS) will acquire 97.97% of the shares of Asa Ren Pte. Ltd, an AI-based DNA data company registered in Singapore, with a transaction value estimated at IDR 357.89 billion.
Diagnos Laboratorium reported its first loss since debut
05 Mar 2024 11:35
PT Diagnos Laboratorium Utama Tbk (DGNS), a medical laboratory service provider under PT Bundamedik Tbk (BMHS), booked a loss of IDR 13.65 billion in 2023.
COVID-19 crisis subsides, Diagnos Lab eyes 2023 realistically
19 Jun 2023 11:49
PT Diagnos Laboratorium Utama Tbk (DGNS), a clinical laboratory service provider under Bundamedik Group, is anticipating the decline in its revenue and profit post COVID-19 crisis.
